Article
Identification of solute carrier family genes related to the prognosis and tumor-infiltrating immune cells of pancreatic ductal adenocarcinoma
1 Jan 2022
Abstract excerpt
Background: Pancreatic ductal adenocarcinoma (PDAC) has persisted as one of the worst prognostic tumors with a 5-year survival rate of lower than 6%. Although many studies have investigated PDAC, new biomarkers are required to ensure early diagnosis and predict the prognosis of PDAC. Methods: In this study, we used bioinformatics methods to evaluate differences in the expression of solute carrier (SLC) family...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
